Inherited Apolipoprotein A-V Deficiency in Severe Hypertriglyceridemia

OBJECTIVE—Mutations in LPL or APOC2 genes are recognized causes of inherited forms of severe hypertriglyceridemia. However, some hypertrigliceridemic patients do not have mutations in either of these genes. Because inactivation or hyperexpression of APOA5 gene, encoding apolipoprotein A-V (apoA-V),...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Arteriosclerosis, thrombosis, and vascular biology thrombosis, and vascular biology, 2005-02, Vol.25 (2), p.411-417
Hauptverfasser:	Oliva, Claudio Priore, Pisciotta, Livia, Volti, Giovanni Li, Sambataro, Maria Paola, Cantafora, Alfredo, Bellocchio, Antonella, Catapano, Alberico, Tarugi, Patrizia, Bertolini, Stefano, Calandra, Sebastiano
Format:	Artikel
Sprache:	eng
Schlagworte:	Amino Acid Substitution Apolipoprotein A-V Apolipoproteins - blood Apolipoproteins - deficiency Apolipoproteins - genetics Apolipoproteins A Atherosclerosis (general aspects, experimental research) Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Cardiovascular system Child Consanguinity Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous DNA Mutational Analysis Enzyme Activation Exons - genetics Fatty Acids, Omega-3 - therapeutic use Genotype Humans Hyperlipoproteinemia Type IV - blood Hyperlipoproteinemia Type IV - drug therapy Hyperlipoproteinemia Type IV - genetics Italy Lipids - blood Lipoprotein Lipase - blood Lipoproteins - blood Male Medical sciences Mutation, Missense Pedigree Pharmacology. Drug treatments Point Mutation RNA, Messenger - biosynthesis RNA, Messenger - genetics Tunisia - ethnology Vasodilator agents. Cerebral vasodilators
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!